puzzle picture
200: Mini-CASP 4-Freestyle
Status: Closed


Name: 200: Mini-CASP 4-Freestyle
Status: Closed
Created: 09/22/2009
Points: 100
Expired: 09/29/2009 - 23:00
Difficulty: Advanced
Description: Here is the next Mini-CASP target whose solved structure will be released soon. Again we are giving you an extended chain to see what you come up with. This might be very difficult, since this blind prediction has 138 residues, so we will release a Rosetta prediction for this target later this week. Until then, good luck freestyle folding! As suggested in the feedback the secondary structure prediction is posted in the puzzle comments.

Top Groups

1Richard Dawkins Foundation10,660100
2Another Hour Another Point10,45366
3Void Crushers10,44242
4Russian team10,32826

Top Evolvers

Top Soloists

1aap 51 1376 Richard Dawkins Foundation10,660100
2MellyLam 51 1376 10,44695
3steveB 51 1376 Void Crushers10,44090
4Mark- 51 1376  10,36585
5justjustin 51 1376 10,28181

Need this puzzle? Log in to download.  


beta_helix's picture
User offline. Last seen 15 hours 27 min ago. Offline
Joined: 05/09/2008
Groups: None
secondary structure prediction results:

Here is the sequence logo predicted by the SAM server.

H = helix
E = sheet
C = loop (or coil)

The taller the letter at each position, the higher the probability of that specific secondary structure for that amino acid.

For example, the amino acid Cysteine at residue 110 is highly predicted to be part of a helix. However, the Leucine at residue 64 is predicted to have an equal probability of being anything.

User login
Download links:
  Windows    OSX    Linux  
(10.12 or later)

Are you new to Foldit? Click here.

Are you a student? Click here.

Are you an educator? Click here.
Social Media

Only search fold.it
Other Games: Mozak
Recommend Foldit
Top New Users

Developed by: UW Center for Game Science, UW Institute for Protein Design, Northeastern University, Vanderbilt University Meiler Lab, UC Davis
Supported by: DARPA, NSF, NIH, HHMI, Amazon, Microsoft, Adobe, Boehringer Ingelheim, RosettaCommons